![](/img/cover-not-exists.png)
Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer
Massard, Christophe, Chi, Kim Nguyen, Castellano, Daniel, de Bono, Johann, Gravis, Gwenaelle, Dirix, Luc, Machiels, Jean-Pascal, Mita, Alain, Gonzalez, Begona Mellado, Turri, Sabine, Maier, Joan, CsonVolume:
76
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2017.01.024
Date:
May, 2017
File:
PDF, 456 KB
english, 2017